Bid Publish Date
18-Feb-2026, 1:12 pm
Bid End Date
05-Mar-2026, 2:00 pm
Location
Progress
Quantity
25000
The issuing government procurement authority seeks supply of Medicine Name, Dosage Form, and Strength across inpatient and outpatient services. Contract scope covers primary packaging and pack size specifications, with requirement for a valid drug manufacturing license under the Drugs and Cosmetics Act, and submission of all required certifications at bid submission. Emphasis on compliance with uploaded special terms and conditions, and shelf life data from date of manufacture to ensure product viability. The tender includes an option clause to adjust quantity up to 50% during contract, with extended delivery timelines calculated per additional quantity. The packaging and regulatory compliance differentiators drive supplier evaluation for reliability and traceability. This tender targets suppliers experienced in government or PSU medical supply chains, with Make in India authorisation and integrity pact compliance as critical screening factors. Unique aspects include hospital supply classification and explicit packaging details to ensure product safety and readability at scale.
Medicine Name, Dosage Form, Strength as per product information
Type of primary packing and Primary pack size (Number of tablets in a pack)
Valid drug manufacturing license under Drugs and Cosmetic Act
Submission of all certifications/test reports at bid submission and with supplies
Shelf life in months from date of manufacture
EMD exemption possible for MSME/NSIC with proper certificate
Make in India authorisation mandatory; integrity pact upload required
Option to adjust quantity by up to 50% at contract placement and during currency
Delivery period aligned to extended quantities with minimum 30 days rule
Hospital supply not for sale instruction to be followed
Details not fully specified; bidders should anticipate standard government terms post-delivery and verification
Delivery must align with order quantity; extension rules apply under option clause with calculated timelines
Not explicitly stated; implied through delivery and performance terms in ATC and buyer policy
Experience certificate for supply of medicines to Govt/PSU or renowned private organisations
MSME/NSIC exemption certificate if applicable
Make in India authorisation and signed integrity pact
Main Document
CATALOG Specification
OTHER
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
| Category | Specification | Requirement |
|---|---|---|
| PRODUCT INFORMATION | Medicine Name | Chlorpromazine |
| PRODUCT INFORMATION | Dosage Form | Tablet |
| PRODUCT INFORMATION | Strength | 100 mg |
| PRODUCT INFORMATION | Compliance to uploaded Special Terms and Conditions | Yes |
| PACKAGING | Type of primary packing | Strip |
| PACKAGING | Primary pack size (Number of tablets in a primary pack) | 10 |
| CERTIFICATIONS & REPORTS | Availability of valid drug manufacturing license issued from the competent authority defined under Drugs and Cosmetic Act and Rules there under as amended till date | Yes |
| CERTIFICATIONS & REPORTS | Submission of all necessary certifications, licenses and test reports to the buyer as per buyer requirement at the time of bid submission and along with supplies | Yes |
| SHELF LIFE | Shelf life in months from the date of manufacture | 24, 36 Or higher |
Discover companies most likely to bid on this tender
GST registration certificate
Permanent Account Number (PAN) card
Experience certificates for supply to Govt/PSU/private organisations
Financial statements (as required by buyer)
EMD submission proof or MSME/NSIC exemption certificate
Drug manufacturing license issued under Drugs and Cosmetic Act
Make in India authorisation certificate
OEM authorisation (if applicable)
Signed integrity pact (as per buyer policy)
Technical compliance certificates and test reports as required by buyer
Key insights about DELHI tender market
Bidders must submit: GST, PAN, experience certificates, financials, EMD or MSME exemption, drug manufacturing license under Drugs and Cosmetics Act, Make in India authorization, OEM authorisations, signed integrity pact, and all technical compliance reports. Ensure shelf life data is provided and packaging details match tender specs.
Required docs include GST registration, PAN, experience certificates for Govt/PSU supply, financial statements, EMD proof or exemption, valid drug manufacturing license, Make in India certificate, OEM authorisation, signed integrity pact, and all applicable test reports per buyer terms.
Tender requires a defined Type of primary packing, specific pack size (number of tablets per pack), and shelf life in months from the date of manufacture. All packaging must maintain product integrity and comply with approved labels per Drugs and Cosmetics Act.
Bidders must provide a Make in India authorisation certificate as part of bid submission. This certifies manufacturing or sourcing compliance within India and is mandatory to participate in the hospital supply tender.
The purchaser may increase or decrease the ordered quantity up to 50% of bid quantity at contract placement and during currency. Delivery timelines adjust using a defined formula, with minimum 30 days extension where applicable.
Submit the valid drug manufacturing license under Drugs and Cosmetics Act, along with all required certifications and test reports. Ensure licenses remain current through bid submission and during supply, and provide any buyer-specified compliance documents.
Bidders must upload a scanned signed Integrity Pact as per buyer policy. Ensure MSME/NSIC certificates if exemption applies, and provide all OEM/authentication documents to confirm non-collusive and compliant bidding practices.
Delivery terms align with the order quantity, with potential extended timelines for increased batches. Payment terms follow government norms after delivery verification and certification, with no explicit advance specified in the data; bidders should confirm post-bid terms with the buyer.
Sign up now to access all documents
Main Document
CATALOG Specification
OTHER
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS